Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system

BACKGROUND: COVID-19 outcomes, in the context of immune-mediated inflammatory diseases (IMIDs), are incompletely understood. Reported outcomes vary considerably depending on the patient population studied. It is essential to analyse data for a large population, while considering the effects of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Qi, Mease, Philip J., Chiorean, Michael, Iles-Shih, Lulu, Matos, Wanessa F., Baumgartner, Andrew, Molani, Sevda, Hwang, Yeon Mi, Belhu, Basazin, Ralevski, Alexandra, Hadlock, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327270/
https://www.ncbi.nlm.nih.gov/pubmed/37425752
http://dx.doi.org/10.1101/2023.06.26.23291904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327270/
https://www.ncbi.nlm.nih.gov/pubmed/37425752
http://dx.doi.org/10.1101/2023.06.26.23291904

Ejemplares similares